Proscia and Proteocyte AI have signed an agreement to integrate Proscia’s technology with the Straticyte test for predicting the risk of progression to oral cancer.
Read MoreQiagen has launched two novel liquid biopsy panels for the evaluation of circulating tumor cells, in the growing field of research into the molecular mechanisms of prostate and lung cancers.
Read MoreCertain types of cancer—including some non-small cell lung cancers—abnormally overexpress PD-L1 on the surface of their cells.
Read More
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read More
The United Kingdom’s 100,000 Genomes Project, led by Genomics England and Illumina, has reached a major milestone by sequencing 50,000 genomes.
Read More